These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. He A, Song D, Zhang L, Li C. J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376 [Abstract] [Full Text] [Related]
10. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment. Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J. Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115 [Abstract] [Full Text] [Related]
12. Are antiepileptic drugs used in the treatment of migraine associated with an increased risk of suicidality? Kanner AM. Curr Pain Headache Rep; 2011 Jun; 15(3):164-9. PubMed ID: 21479999 [Abstract] [Full Text] [Related]
15. Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability. D'Amico D. Neurol Sci; 2007 May; 28 Suppl 2():S188-97. PubMed ID: 17508169 [Abstract] [Full Text] [Related]
16. Long-term migraine prevention with topiramate: open-label extension of pivotal trials. Rapoport A, Mauskop A, Diener HC, Schwalen S, Pfeil J. Headache; 2006 May; 46(7):1151-60. PubMed ID: 16866719 [Abstract] [Full Text] [Related]
17. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Chengappa KN, Gershon S, Levine J. Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568 [Abstract] [Full Text] [Related]
19. [The role of the neuromodulators in the preventive treatment of migraine]. Pascual-Gómez J. Rev Neurol; 2001 Oct; 49(1):25-32. PubMed ID: 19557697 [Abstract] [Full Text] [Related]